Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine

Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

1999 • 1,095 citations

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

2003 • 1,016 citations

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine

1998 • 808 citations

Management of hepatitis B: 2000—Summary of a workshop

2001 • 789 citations

Chronic hepatitis B

2001 • 694 citations

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

1999 • 516 citations

A Multicenter United States—Canadian Trial to Assess Lamivudine Monotherapy Before and After Liver Transplantation for Chronic Hepatitis B

2001 • 424 citations

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

2000 • 422 citations

Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region

2001 • 388 citations

Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B

1995 • 384 citations

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

1998 • 374 citations

Efficacy of Long-Term Lamivudine Monotherapy in Patients With Hepatitis B e Antigen–Negative Chronic Hepatitis B

2000 • 365 citations

World‐wide epidemiology of HBeAg‐negative chronic hepatitis B and associated precore and core promoter variants

2002 • 363 citations

Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach

2001 • 362 citations

Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study

2002 • 335 citations

Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study

1994 • 305 citations

Molecular diagnosis of viral hepatitis

2002 • 250 citations

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

2000 • 246 citations

The long-term course of chronic hepatitis B

1999 • 245 citations

The long-term outcome of interferon-α treated and untreated patients with HbeAg-negative chronic hepatitis B

2001 • 231 citations

Long-Term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy

2003 • 221 citations

Interferon α Treatment and Retreatment of Hepatitis B e Antigen-Negative Chronic Hepatitis B

2001 • 220 citations

Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease

2002 • 206 citations

Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy

1999 • 198 citations

Hepatitis B e antigen-negative chronic hepatitis b in Hong Kong

2000 • 193 citations

Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection

2000 • 187 citations

Line Probe Assay for Monitoring Drug Resistance in Hepatitis B Virus-Infected Patients during Antiviral Therapy

2000 • 183 citations

Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus

1995 • 182 citations

A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum

1997 • 178 citations

Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B

2000 • 161 citations

Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis

2000 • 152 citations

Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea

2002 • 104 citations

Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study

2002 • 98 citations

A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus–related cirrhosis

2003 • 64 citations

Comparison of anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in France

1994 • 63 citations

Epidemiology of precore mutants of hepatitis B in the United Kingdom

2000 • 22 citations

Re‐treatment of patients with anti‐HBe‐positive chronic hepatitis B who relapsed after an initial course of lamivudine

2003 • 5 citations

Cited By (0)

Loading...